StonvexLoading…
StonvexStonvexStonvexCore line items from HCTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.14M | $18.36M | $9.84M | $45.89M |
Operating Income | $-6.33M | $-4.80M | $-3.21M | $-16.32M |
Net Income | $-7.01M | $-5.06M | $-3.28M | $-14.36M |
EPS (Diluted) | $-1.65 | $-1.20 | $-0.79 | $-3.88 |
Total Assets | $14.47M | $16.07M | $18.86M | $13.26M |
Total Liabilities | $8.34M | $8.02M | $9.56M | $7.22M |
Cash & Equivalents | $75.00K | $132.00K | $267.00K | $1.34M |
Free Cash Flow OCF − CapEx | $-2.76M | $-2.75M | $-1.61M | $-5.39M |
Shares Outstanding | 4.28M | 4.28M | 41.86M | 4.17M |